Related Experiment Video

Updated: May 14, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

41.5K

Blood microbial DNA signature differentiates hepatocellular carcinoma from metastatic lesions

Caitlin Guccione1,2,3, Ana Carolina Dantas Machado4, Fady Youssef4,5

  • 1Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California, USA.

Egastroenterology
|August 22, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Carcinoma, HepatocellularCell-Free Nucleic AcidsColorectal NeoplasmsDigestive System NeoplasmsGastrointestinal CancerLiver NeoplasmsMicrobiotaNeoplasm Metastasis

More Related Videos

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.5K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

290

Related Experiment Videos

Last Updated: May 14, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

41.5K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.5K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

290

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Articles linked to this work by shared authors, journal, and citation graph.

Megascale microbiome analysis with DartUniFrac.

Nature biotechnology·2026

Thiazolidinedione Use and Risk of Bacterial Enteric Infection Among Adults With Type 2 Diabetes Mellitus.

Open forum infectious diseases·2026

Joint-RPCA: domain-aware multi-omics integration for systems microbiology.

Molecular systems biology·2026

Integrated multi-omics analysis identifies microbial and metabolic signatures and drivers of CNS autoimmunity.

mSystems·2026

Applying Artificial Intelligence and machine learning in precision nutrition.

Nature communications·2026

Impact of Intrapatient Immunosuppression Variability in Renal Transplantation Outcomes: A Systematic Review and Meta-analysis.

Transplantation·2026

Liver-nervous system axis in MASLD: mechanistic insights and emerging targeted therapies.

eGastroenterology·2026

Plasma cell-CD8+ T cell co-enrichment distinguishes immunotherapy-responsive hepatocellular carcinoma subtypes.

eGastroenterology·2026

Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary strictures.

eGastroenterology·2026

Intestinal neutral ceramidase exacerbates MASH pathogenesis.

eGastroenterology·2026

TERT rs10069690 variant is linked to reduced cholangiocarcinoma incidence but adverse prognosis in patients undergoing resection.

eGastroenterology·2026

Unified platform for multiplex immunofluorescence across liver tissues and engineered models.

eGastroenterology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us